ITI Pharma and Healthcare Fund Regular vs SBI Healthcare Opportunities Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹217 Cr | ₹3522 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 31 Dec 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 32% |
Expense Ratio | 2.35 | 1.94 |
Manager | Rohan Korde | Pradeep Kesavan |
ISIN Code | INF00XX01BL5 | INF200K01446 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Month | 7.5% | 6.96% |
6 Month | -7.98% | -2.35% |
1 Year | 15.63% | 19.83% |
3 Year | 18% | 22.87% |
5 Year | - | 29.3% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
6 Month | -6.22% | -1.91% |
1 Year | 0.97% | 10.16% |
3 Year | 22.66% | 28.36% |
5 Year | - | 22.98% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Year | 22.47% | 15.04% |
3 Year | 18.57% | 17.32% |
5 Year | - | 12.58% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Standard Deviation | 15.667% | 14.597% |
Sharp | 0.739% | 0.987% |
Beta | 0.959% | 0.85% |
Alpha | -1.413% | 4.505% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Name | Rohan Korde | Pradeep Kesavan |
Total AUM | ₹4626 Cr | ₹434274 Cr |
Funds Managed | 10 | 43 |
ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 7.57 | 6.48 |
Mid Cap | 31.22 | 28.02 |
Small Cap | 32.03 | 37.63 |
Large Cap | 29.19 | 27.87 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 8.42 | 1.8 |
Healthcare | 88.76 | 91.34 |
Basic Materials | 2.08 | 6.85 |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Top Comparisons
Nippon India Nifty Smallcap 250 Index Fund - Regular Plan - Growth Option
3Y Returns16.01%
HSBC NIFTY 50 INDEX FUND - Regular Growth
3Y Returns11.14%
Franklin India Banking & PSU Debt Fund - Growth
3Y Returns6.33%
Aditya Birla Sun Life Banking & PSU Debt Fund - Regular Plan-Growth
3Y Returns6.56%
Canara Robeco CorpoRate Bond Fund - Regular Plan - Growth Option
3Y Returns5.9%
Mirae Asset Corporate Bond Fund Regular Growth
3Y Returns6.16%
PGIM India Hybrid Equity Fund - Growth Option
3Y Returns9.88%
HSBC Aggressive Hybrid Fund - Regular Growth
3Y Returns10.35%